AN2 Therapeutics, Inc.
Industry: Life Sciences ・ $ANTX on Nasdaq
Insider Purchase
+$2,800
+0.38%
Shares
Shares Volume: 2,000 Shares
Average Share Price: $1.4
INSIDER
Zakrzewski Joseph S
Director
reported on Nov 27 2024
traded on Nov 27 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 531,079 |
| PURCHASES/SALES 1Y | 2 / 1 |
| P/S VALUE RATIO | 0.015 |
| AVERAGE PURCHASE VALUE | $13,900 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 3 / 0 |
| PURCHASES/SALES 1Y | 5 / 11 |
| P/S VALUE RATIO | 0.185 |
| AVERAGE PURCHASE VALUE | $371,560 |
| COMPANY PREVIOUS TRADES |